Vista Pharmaceuticals Ltd.BSE: VISTAPH

Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter Ended 30.06.2025

· Issued by Vista Pharmaceuticals Ltd. via BSE India

Filed with BSE ·

Vista Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2025 ,inter alia, to consider and approve 1. Unaudited Financial Results for the quarter ended 30.06.20252. Limited Review Report for the quarter ended 30.06.20253. Any other business with the permission of the chair.

View Attachment

6ix hasn’t read this filing yet.

View original source (BSE India)Vista Pharmaceuticals Ltd. on 6ix

Story so far

Earlier from Vista Pharmaceuticals

Later from Vista Pharmaceuticals

All Vista Pharmaceuticals news releases